Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture.
FARMS: A New Algorithm for Variable Selection.
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.